Form 4 for VMD VIEMED HEALTHCARE, INC.
Accepted 2026-01-23 00:00:00 ET · period of report 2026-01-21 · accession 0001429216-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-23 | 2026-01-21 | VMD | ZEHNDER WILLIAM TODD | COO, Dir | M - OptEx | — | +126.1K | 409.9K | +44% | — |
| D | 2026-01-23 | 2026-01-21 | VMD | ZEHNDER WILLIAM TODD | COO, Dir | D - Sale to Iss | $7.49 | -8,554 | 374.8K | -2% | -$64.1K |
| D | 2026-01-23 | 2026-01-21 | VMD | ZEHNDER WILLIAM TODD | COO, Dir | F - Tax | $7.49 | -35.1K | 374.8K | -9% | -$262.7K |
| DM | 2026-01-23 | 2026-01-21 | VMD | ZEHNDER WILLIAM TODD | COO, Dir | M - OptEx | $0.00 | -126.1K | 17.1K | -88% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-01-21 | M | A | 8,554 | — | 383,389 | D | — | — | (F4) Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. |
| 2 | Common | Common Shares | 2026-01-21 | D | D | 8,554 | $7.49 | 374,835 | D | — | — | (F3) Per share value is based on the market closing price of the common shares for January 21, 2026. |
| 3 | Common | Common Shares | 2026-01-21 | M | A | 117,548 | — | 409,910 | D | — | — | (F1) Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. |
| 4 | Common | Common Shares | 2026-01-21 | F | D | 35,075 | $7.49 | 374,835 | D | — | — | (F2) Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. (F3) Per share value is based on the market closing price of the common shares for January 21, 2026. |
| 5 | Derivative | Restricted Stock Units | 2026-01-21 | M | D | 117,548 | $0.00 | 235,094 | D | — · — to 2028-01-21 | 117,548 Common Shares | (F1) Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. (F5) Restricted Stock Units (RSUs) granted to reporting person on January 21, 2025, which vest in three equal annual installments beginning on the first anniversary of the grant date. |
| 6 | Derivative | Phantom Share Units | 2026-01-21 | M | D | 8,554 | — | 17,107 | D | — · — to 2028-01-21 | 8,554 Common Shares | (F4) Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. (F6) Represents an award granted on January 21, 2025 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date. |